FDA Inspection 1058050 — Pharmascience Inc.
The FDA completed an inspection of Pharmascience Inc. on May 25, 2018 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional details
Bioanalytical BA/BE